Serum levels of aminoterminal type III procollagen peptide in normal subjects and hepatic fibrosis. 1985

H Nakano, and H Nakabayashi, and Y Okamoto, and T Kawasaki, and S Seko, and Y Fukuda

Serum levels of aminoterminal type III procollagen peptide in normal subjects were determined by radioimmunoassay. The levels of the peptide markedly increase in infants and gradually decrease with age in childhood. The peptide increases again in prepubertal children and then decreases through adulthood. These findings suggest that increased levels of the peptide reflect accelerated collagen synthesis in the human body. Comparison of serum levels of the peptide with the degree of hepatic fibrosis revealed that the peptide increased in parallel with the progress of hepatic fibrosis.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011347 Procollagen A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains. Protocollagen,Procollagen Type M
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic

Related Publications

H Nakano, and H Nakabayashi, and Y Okamoto, and T Kawasaki, and S Seko, and Y Fukuda
April 1986, The British journal of dermatology,
H Nakano, and H Nakabayashi, and Y Okamoto, and T Kawasaki, and S Seko, and Y Fukuda
March 2005, The British journal of dermatology,
H Nakano, and H Nakabayashi, and Y Okamoto, and T Kawasaki, and S Seko, and Y Fukuda
January 1992, Scandinavian journal of rheumatology,
H Nakano, and H Nakabayashi, and Y Okamoto, and T Kawasaki, and S Seko, and Y Fukuda
December 1983, American journal of hematology,
H Nakano, and H Nakabayashi, and Y Okamoto, and T Kawasaki, and S Seko, and Y Fukuda
December 1988, British journal of rheumatology,
H Nakano, and H Nakabayashi, and Y Okamoto, and T Kawasaki, and S Seko, and Y Fukuda
January 1990, Veterinary clinical pathology,
H Nakano, and H Nakabayashi, and Y Okamoto, and T Kawasaki, and S Seko, and Y Fukuda
March 1988, Clinical rheumatology,
H Nakano, and H Nakabayashi, and Y Okamoto, and T Kawasaki, and S Seko, and Y Fukuda
May 1992, Medicina clinica,
H Nakano, and H Nakabayashi, and Y Okamoto, and T Kawasaki, and S Seko, and Y Fukuda
July 1996, Journal of hepatology,
H Nakano, and H Nakabayashi, and Y Okamoto, and T Kawasaki, and S Seko, and Y Fukuda
January 1985, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!